Search results
FDA places partial clinical hold on Zentalis’ trials of azenosertib for cancer
Clinical Trials Arena via Yahoo Finance· 5 hours agoThe US Food and Drug Administration (FDA) has placed a partial hold on three of the clinical studies...
Drug reprograms immune responses to target glioblastoma
Medical Xpress· 1 day agoThe findings are published in the...Heimberger, MD, Ph.D., the Jean Malnati Miller Professor of...
AstraZeneca’s Truqap flops in Phase III triple negative breast cancer trial
Clinical Trials Arena via Yahoo Finance· 3 hours agoAstraZeneca has been dealt a blow after its flagship breast cancer drug Truqap (capivasertib) did...
US FDA puts Zentalis' cancer drug studies on partial hold after patient deaths
Reuters via Yahoo News· 1 day agoShares of the drug developer slumped about 26% to $6.22 in early trading. The drug candidate,...
Breakthrough UC San Diego Brain Recording Device R | Newswise
Newswise· 9 hours agoThe Federal Drug Administration approved a clinical trial to test the effectiveness of an electronic...
Day One inks $1.2B biobucks pact for MabCare’s solid tumor ADC
FierceBiotech· 23 hours agoDay One Biopharmaceuticals is offering MabCare Therapeutics up to $1.2 billion for exclusive licensing rights to an antibody drug conjugate (ADC) taking aim at solid tumors ...
FDA grants approval for Bristol Myers Squibb’s Augtyro for solid tumours
Pharmaceutical Technology via Yahoo Finance· 2 days agoThe US Food and Drug Administration (FDA) has granted accelerated approval for Bristol Myers...
Johnson & Johnson submits BLA to FDA for lung cancer drug
Pharmaceutical Technology via Yahoo Finance· 1 day agoJohnson & Johnson has filed a biologics licence application (BLA) with the US Food and Drug...
Psoriatic Arthritis Drugs Comparably Improve Joint Outcomes
Medscape· 9 hours agoReal-world study data suggest there is little difference among five drug classes commonly used to treat PsA in terms of their ability to improve both joint and skin symptoms.
Izokibep Enthesitis Benefit Lacking in Phase 2b/3 PsA Trial
Medscape· 9 hours agoThe primary efficacy endpoint was met, but the novel small molecule therapeutic did not reduce...